Add time:08/27/2019 Source:sciencedirect.com
BackgroundHaemoglobin-based oxygen carriers (HBOCs) are assessed as blood substitutes in patients with perioperative anaemia including patients at risk for perioperative cardiac ischaemia. There is controversy as to whether HBOCs are beneficial or deleterious during ischaemia–reperfusion (I–R). Therefore the effects of HBOC-200 on I–R injury were evaluated in a randomized placebo-controlled animal trial.
We also recommend Trading Suppliers and Manufacturers of hemoglobin South Milwaukee (cas 132822-84-5). Pls Click Website Link as below: cas 132822-84-5 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View